Disclosure of material issue

A C C R E D I T E D ISO/IEC 17021 CERTIFICATION BODY Date: August 12, 2026 To To BSE Limited National Stock Exchange of India Limited 25th Floor, PJ Towers Exchange Plaza, C-1, Block G Dalal Street, Bandra Kurla Complex, Bandra (E) Mumbai – 400001 Mumbai – 400051 Scrip Code: 524654 Symbol: NATCAPSUQ Sub: Intimation under Regulation 30(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, This is to inform you that under Regulation 30(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; Natural Biogenex Private Limited (“Material Unlisted Subsidiary”), at its Board Meeting held on today, has appointed Mr. K. H. Honneshaiah as the new Chief Operating Officer of the Company. Brief Profile: Mr. K. H. Honneshaiah is a Goal-oriented operations leader with 36 years of experience with regulated API and specialty Operations & Manufacturing Leadership across API, Polymers, Peptides & CDMO — three decades of scaling regulated pharma plants, building greenfield capacity and driving profitable growth. Kindly take the aforesaid intimation on record. Thanking You Yours Faithfully, For Natural Capsules Limited Akshay Dutta Company Secretary and Compliance Officer M.No. A80481